Small Molecules

11 Jun 2007 Millennium Advances Aurora A Kinase Program
11 Jun 2007 Clavis Pharma presented preliminary clinical data on ELACYT(TM) at EHA
10 Jun 2007 FROVA (R) Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
10 Jun 2007 Pivotal phase III trial showed RevoladeTM (eltrombopag) raised platelet counts and reduced bleeding in patients with chronic ITP
09 Jun 2007 Promising Data on Cognitive Effects of Safinamide in Early Parkinson's Disease
09 Jun 2007 Renovis Announces Achievement of Milestones in VR1 Collaboration with Pfizer Inc.
09 Jun 2007 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain
09 Jun 2007 Efficacy of Boehringer Ingelheim's pramipexole (Mirapexin(R)/Sifrol(R)) also demonstrated in patients with daytime RLS symptoms
08 Jun 2007 Teva And Active Biotech To Initiate Pivotal Phase III Trial Program Of Oral Laquinimod For Relapsing Multiple Sclerosis
08 Jun 2007 Merck's Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
08 Jun 2007 Prana Biotechnology Presents New Key Findings on PBT2
08 Jun 2007 Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
08 Jun 2007 Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
08 Jun 2007 OREXIGEN(TM) Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
08 Jun 2007 Dynogen reports positive results in Phase 1b gerd study
08 Jun 2007 Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent® at European Association for Palliative Care Congress
07 Jun 2007 XTL Provides Update on Phase I Clinical Trial of XTL-2125
07 Jun 2007 Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Society's Annual Meeting
07 Jun 2007 Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease Presented at International Congress of Parkinson's Disease and Movement Disorders
07 Jun 2007 Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
07 Jun 2007 Anacor clinical study of AN2728, a novel anti-inflammatory compound, shows efficacy in psoriasis
07 Jun 2007 Movetis Announces Start of a Phase IIa Trial for M0002 in Ascites
07 Jun 2007 Surface Logix Starts Phase 2a Clinical Trial of SLx-4090 in Dyslipidemia
07 Jun 2007 Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
06 Jun 2007 Phase 2 results for EentreMmed’s Ppanzem® NCD brain cancer study presented at ASCO

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing